Compare ChemoMetec A/S with Similar Stocks
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-56.55%
0%
-56.55%
6 Months
-52.25%
0%
-52.25%
1 Year
-41.59%
0%
-41.59%
2 Years
-29.32%
0%
-29.32%
3 Years
-21.68%
0%
-21.68%
4 Years
-62.17%
0%
-62.17%
5 Years
-46.96%
0%
-46.96%
ChemoMetec A/S for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
15.16%
EBIT Growth (5y)
18.61%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.44
Sales to Capital Employed (avg)
0.91
Tax Ratio
23.29%
Dividend Payout Ratio
65.35%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
82.06%
ROE (avg)
35.33%
Valuation key factors
Factor
Value
P/E Ratio
41
Industry P/E
Price to Book Value
11.01
EV to EBIT
29.91
EV to EBITDA
28.31
EV to Capital Employed
18.17
EV to Sales
14.02
PEG Ratio
8.63
Dividend Yield
3.39%
ROCE (Latest)
60.76%
ROE (Latest)
27.13%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Jun'25
Jun'25
Jun'24
Change(%)
Net Sales
495.60
407.30
21.68%
Operating Profit (PBDIT) excl Other Income
247.70
178.30
38.92%
Interest
0.60
0.20
200.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
186.40
136.30
36.76%
Operating Profit Margin (Excl OI)
477.30%
413.50%
6.38%
USD in Million.
Net Sales
YoY Growth in year ended Jun 2025 is 21.68% vs -7.91% in Jun 2024
Consolidated Net Profit
YoY Growth in year ended Jun 2025 is 36.76% vs -23.73% in Jun 2024
About ChemoMetec A/S 
ChemoMetec A/S
Pharmaceuticals & Biotechnology
Chemometec A/S is a Denmark-based company engaged in the development, manufacture and sale of analytical instruments used for quantitative analysis of cells in liquids. The Company’s activities are divided into three business areas: Instruments, which offers a range of NucleoCounter analytical instruments for counting mammalian, animal, yeast and sperm cells, as well as somatic cells in milk, among others; Consumables, which distributes disposable cassettes, solutions, reagents and slides; and Other, which is responsible for the partnership development in a number of research projects, among others. The Company’s analytical products are based on a technology, which combines fluorescence microscopy with digital imagery. Its customer portfolio comprises entities active primarily within pharmaceutical, food processing and agriculture industries. Furthermore, the Company is a parent of ChemoMetec USA Inc.






